Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion

被引:13
作者
Gomara, Maria J.
Lorizate, Maier
Huarte, Nerea
Mingarro, Ismael
Perez-Paya, Enrique
Nieva, Jose L.
机构
[1] Univ Basque Country, EHU, CSIC, Biofis Unit, E-48080 Bilbao, Spain
[2] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Valencia, Spain
[3] Ctr Invest Principe Felipe, E-46013 Valencia, Spain
[4] CSIC, E-46013 Valencia, Spain
来源
FEBS LETTERS | 2006年 / 580卷 / 11期
关键词
membrane fusion; viral fusion; gp41; HIV-1; fusion peptide; fusion inhibitor;
D O I
10.1016/j.febslet.2006.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon receptor-mediated activation, the gp41 hydrophobic, conserved fusion peptide inserts into the target membrane and promotes the kind of perturbations required for the progression of the HIV-cell fusion reaction. Using a synthetic combinatorial library we have identified all D-amino acid hexapeptide sequences that inhibited the fusion peptide capacity of perturbing model membranes. Two hexapeptides that effectively inhibited the fusion peptide in these systems were subsequently shown to inhibit cell-cell fusion promoted by gp41 expressed at cell surfaces. These observations might be of importance for understanding the mechanisms underlying fusion peptide activity and suggest new strategies for screening compounds that target these viral sequences. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2561 / 2566
页数:6
相关论文
共 43 条
[1]  
AUCI A, 1996, NATURE, V384, P529
[2]   SOLUBLE COMBINATORIAL LIBRARIES OF ORGANIC, PEPTIDOMIMETIC AND PEPTIDE DIVERSITIES [J].
BLONDELLE, SE ;
PEREZPAYA, E ;
DOOLEY, CT ;
PINILLA, C ;
HOUGHTEN, RA .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1995, 14 (02) :83-92
[3]   IDENTIFICATION OF THE FUSION PEPTIDE OF PRIMATE IMMUNODEFICIENCY VIRUSES [J].
BOSCH, ML ;
EARL, PL ;
FARGNOLI, K ;
PICCIAFUOCO, S ;
GIOMBINI, F ;
WONGSTAAL, F ;
FRANCHINI, G .
SCIENCE, 1989, 244 (4905) :694-697
[4]   Interaction of fusion peptides from HIV gp41 with membranes:: A time-resolved membrane binding, lipid mixing, and structural study [J].
Buzón, V ;
Padrós, E ;
Cladera, J .
BIOCHEMISTRY, 2005, 44 (40) :13354-13364
[5]   Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy [J].
Castano, S ;
Desbat, B .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1715 (02) :81-95
[6]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[7]   INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
CONNOR, RI ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1772-1777
[8]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[9]   HIV-1 membrane fusion: Targets of opportunity [J].
Doms, RW ;
Moore, JP .
JOURNAL OF CELL BIOLOGY, 2000, 151 (02) :F9-F13
[10]   What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion [J].
Durell, SR ;
Martin, I ;
Ruysschaert, JM ;
Shai, Y ;
Blumenthal, R .
MOLECULAR MEMBRANE BIOLOGY, 1997, 14 (03) :97-112